Skip to main content
. 2022 May 17;11(5):982. doi: 10.3390/antiox11050982
A-wave late diastolic mitral flow velocity
AGE advanced glycation end products
ANOVA analysis of variance
AO aorta diameter
C control group
C + DAPA control group treated with dapagloflozin
DAB 3,3′-diaminobenzidine
DM diabetes mellitus
DM + DAPA diabetes mellitus group treated with dapagloflozin
E-wave early diastolic mitral flow velocity
E/A ratio
E/E’ ratio
EDT E-wave deceleration time
EDTA ethylenediamine tetraacetic acid
EFS endocardial fraction shortening
GSH-Px glutathione peroxidase
HOP hydroxyproline
H2O2 Hydrogen peroxide
IVRT isovolumetric relation time
LA left atrium
LV left ventricle
LVDD left ventricle diastolic dimensions
LVPWT left ventricle posterior wall thickness
LVM left ventricle mass
LVSWT left ventricle septal wall thickness
LVSD left ventricle sistolic dimensions
NADH nicotinamida adenina dinucleotídeo
PWSV posterior wall shortening velocity
RWT left ventricle relative wall thickness
SGLT2 sodium-glucose co-transporter 2
SOD superoxide dismutase
TDI tissue Doppler imaging
TDI-A’ tissue Doppler imaging of mitral annular late velocity (lateral, septal and average)
TDI-E’ tissue Doppler imaging of mitral annular early velocity (lateral, septal and average)
TDI-S’ tissue Doppler imaging for systolic velocity of the mitral annulus (lateral, septal and average)
Tei index myocardial performance index